Arakena Pharmaceuticals AG
Pharmaceuticals · Basel, Basel-Stadt
Arakena Pharmaceuticals AG is a Swiss pharmaceuticals company based in Basel, Canton of Basel-Stadt, listed in the Swiss commercial register since 2024 (UID CHE-351.058.572).
Board members & signatories
- Dr. Oliver Nayler — Präsident des Verwaltungsrates
- Dr. Martin Bolli — Mitglied des Verwaltungsrates
- Dr. Ravindrakumar Sodha — Mitglied des Verwaltungsrates
Registered purpose
Die Gesellschaft bezweckt die Entdeckung, Entwicklung, Herstellung, und den Verkauf von pharmazeutischen und anderen Produkten im Gesundheitsbereich sowie die Entwicklung, das Halten und Verwerten von Immaterialgüterrechten in diesen Bereichen. Die Gesellschaft kann Beratungsdienstleistungen im Life Sciences Bereich erbringen und alle Geschäfte tätigen und Massnahmen ergreifen, die geeignet sind, …
Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026
What Arakena Pharmaceuticals does
OFFERING
Arakena Pharmaceuticals focuses on the discovery and development of GRK5 inhibitors as a treatment for cardiomyopathies. The company has secured an exclusive option-to-license intellectual property from a major US-based university, which includes three structural classes of potent compounds with various GRK selectivity profiles.
Unlock the full analysis →Similar companies
- Adagene AG — Pharmaceuticals · Basel
- Ardanza Biopharma AG — Biotechnology · Zug
- Anaveon AG — Pharmaceuticals · Basel
- argenx Switzerland SA — Pharmaceuticals · Châtelaine
- Denali Therapeutics CH GmbH — Pharmaceuticals · Zürich
- Alphathera AG — Pharmaceuticals · Basel
Find every pharmaceuticals company in Switzerland
Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.
family-owned pharmaceuticals companies with 50+ employees…Search →Full profiles from CHF 49/month · Cancel anytime